{"id":"https://openalex.org/W2000761851","doi":"https://doi.org/10.1007/bf00431989","title":"Protection by 4-amino-hex-5-enoic acid (?-vinyl GABA) and hypobaric hypoxia against kainic acid neurotoxicity","display_name":"Protection by 4-amino-hex-5-enoic acid (?-vinyl GABA) and hypobaric hypoxia against kainic acid neurotoxicity","publication_year":1979,"publication_date":"1979-11-01","ids":{"openalex":"https://openalex.org/W2000761851","doi":"https://doi.org/10.1007/bf00431989","mag":"2000761851","pmid":"https://pubmed.ncbi.nlm.nih.gov/120542"},"language":"en","primary_location":{"id":"doi:10.1007/bf00431989","doi":"https://doi.org/10.1007/bf00431989","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00431989","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033346225","display_name":"Pierre M. Lenicque","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. M. Lenicque","raw_affiliation_strings":["Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, F-92290, Chatenay-Malabry, France","Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, Chatenay-Malabry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, F-92290, Chatenay-Malabry, France","institution_ids":["https://openalex.org/I1294671590"]},{"raw_affiliation_string":"Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, Chatenay-Malabry, France","institution_ids":["https://openalex.org/I1294671590"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111703123","display_name":"J. W\u00e9pierre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Wepierre","raw_affiliation_strings":["Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, F-92290, Chatenay-Malabry, France","Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, Chatenay-Malabry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, F-92290, Chatenay-Malabry, France","institution_ids":["https://openalex.org/I1294671590"]},{"raw_affiliation_string":"Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, Chatenay-Malabry, France","institution_ids":["https://openalex.org/I1294671590"]}]},{"author_position":"last","author":{"id":null,"display_name":"Y. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Y. Cohen","raw_affiliation_strings":["Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, F-92290, Chatenay-Malabry, France","Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, Chatenay-Malabry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, F-92290, Chatenay-Malabry, France","institution_ids":["https://openalex.org/I1294671590"]},{"raw_affiliation_string":"Laboratoire de Pharmacodynamie, Equipe de Recherche associ\u00e9e au C.N.R.S. No. 627, Facult\u00e9 de Pharmacie Paris-Sud, Chatenay-Malabry, France","institution_ids":["https://openalex.org/I1294671590"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1294671590"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.0131,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.70722321,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"66","issue":"1","first_page":"51","last_page":"53"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kainic-acid-neurotoxicity","display_name":"kainic acid neurotoxicity","score":0.9319999814033508},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.5419999957084656},{"id":"https://openalex.org/keywords/hypobaric-hypoxia","display_name":"hypobaric hypoxia","score":0.9710000157356262},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9480000138282776},{"id":"https://openalex.org/keywords/excitotoxicity","display_name":"excitotoxicity","score":0.6850000023841858},{"id":"https://openalex.org/keywords/behavioral-effects","display_name":"behavioral effects","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C2776108384","wikidata":"https://www.wikidata.org/wiki/Q390239","display_name":"Kainic acid","level":4,"score":0.9144105315208435},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.7370136380195618},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.7128117680549622},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5756688714027405},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5272765755653381},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.4589894711971283},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3386839032173157},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.33311712741851807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24937152862548828},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22659790515899658},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.198154479265213},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.16222238540649414},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.13614854216575623},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08164817094802856},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000612","descriptor_name":"4-Aminobutyrate Transaminase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000614","descriptor_name":"Aminocaproates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001274","descriptor_name":"Atmospheric Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004327","descriptor_name":"Drinking Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005247","descriptor_name":"Feeding Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007608","descriptor_name":"Kainic Acid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010100","descriptor_name":"Oxygen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00431989","doi":"https://doi.org/10.1007/bf00431989","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00431989","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:120542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/120542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W610173514","https://openalex.org/W1966940145","https://openalex.org/W2029555570","https://openalex.org/W2035352436","https://openalex.org/W2050411378","https://openalex.org/W2887466383"],"related_works":["https://openalex.org/W2085882729","https://openalex.org/W2410232231","https://openalex.org/W2736604720","https://openalex.org/W2419016392","https://openalex.org/W1981161379","https://openalex.org/W2070532293","https://openalex.org/W2045786617","https://openalex.org/W2092058060","https://openalex.org/W1984241984","https://openalex.org/W2025731340"],"abstract_inverted_index":null,"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}